Migraine without aura
Therapeutic area
Neurology
Rare disease
No
- Definition
- A migraine disorder characterized by episodes that occur in the absence of preceding focal neurological symptoms.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Migraine without aura
- Therapeutic area
- Neurology
- migraine without aura
- common migraine
- Severity
- Mild
- Cardiology
- Neurology
- Vascular Medicine
- MONDO ID
- MONDO:0100431
- Parent condition
- MONDO:0005277
Related records
Broader conditions (13)
- Brain disorder
- Cardiovascular disorder
- Central nervous system disorder
- Disease
- Disease by body system or component
- Headache disorder
- Human disease
- Hypnic headache
- Migraine disorder
- Nervous system disorder
- Neurological pain disorder
- Neurovascular disorder
- Vascular disorder
Trials (225)
- 1H Magnetic Resonance Spectroscopy in Migraine Patients
- A Comprehensive Digital Care Program for Migraine Management
- A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Bayesian Adaptive Randomization Design, Dose Response Study of the Efficacy of E2006 in Adults and Elderly Subjects With Chronic Insomnia
- A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
- A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department
- A Randomized Controlled Trial of Acupuncture in Treating Migraine
- A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine
- A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine
- A Randomized, Single-Blind Study Evaluating the Efficacy and Cost-Effectiveness of Brief Behavioral Therapy for Chronic Insomnia Patients Under Medication Treatment At Nguyen Trai Hospital, Ho Chi Minh City
- A Remote, 9-week Insomnia Treatment Trial to Collect Real World Data for a Digital Therapeutic
- A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for Insomnia
- A Study of a Melatonin Receptor Agonist to Prevent Migraine
- A Study of Ramelteon in Chinese Patients With Chronic Insomnia
- A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
- A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine
- A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine
- A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects
- A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine
- ACT Therapy for HF Migraine
- Acupuncture for Migraine Prophylaxis
Drugs in development (16)
- Anisodine hydrobromide Phase 3
- Caffeine Phase 3
- Candesartan Phase 2
- Dihydroergotamine Phase 3
- Dronabinol Phase 2
- Eletriptan Phase 3
- Flunarizine hydrochloride Phase 1
- Promethazine Phase 3
- Propranolol Phase 2
- Ramelteon Phase 2
- Rizatriptan Phase 3
- Rizatriptan benzoate Phase 3
- Sumatriptan Phase 3
- Sumatriptan succinate Phase 3
- Tizanidine hydrochloride Phase 3
- Tonabersat Phase 2
Other linked drugs (3)
- Levcromakalim
- Riociguat
- Sildenafil